Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

251
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
251
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

284
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
284
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
  1. ホーム
  2. 肺がんにおける窒素酸化物,プロスタグランジン,トロンボキサン,エンドセリンの役割:概要
  1. ホーム
  2. 肺がんにおける窒素酸化物,プロスタグランジン,トロンボキサン,エンドセリンの役割:概要

関連する実験動画

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.4K

肺がんにおける窒素酸化物,プロスタグランジン,トロンボキサン,エンドセリンの役割:概要

Sadettin Demirel1, Ipek Nazli Sinag2

  • 1Medicine School, Physiology Department, Bursa Uludag University, Bursa 16059, Türkiye. sdemirel@uludag.edu.tr.

World journal of clinical cases
|August 29, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

窒素酸化物 (NO),プロスタグランジン (PG),トロンボキサン (TX),エンドセリン (ET) は肺がんの発症において重要な役割を果たします. 肺がんの増殖,アポトーシス,血管新生における その役割を理解することは 肺がんの治療をターゲットにするために 極めて重要です

キーワード:
エンドセリン肺がん窒素酸化物プロスタグランディントロンボキサン

さらに関連する動画

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

10.1K
Angiogenesis in the Ischemic Rat Lung
07:36

Angiogenesis in the Ischemic Rat Lung

Published on: February 8, 2013

15.6K

関連する実験動画

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.4K
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
07:52

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

10.1K
Angiogenesis in the Ischemic Rat Lung
07:36

Angiogenesis in the Ischemic Rat Lung

Published on: February 8, 2013

15.6K

科学分野:

  • 腫瘍学
  • 分子生物学
  • 生物化学

背景:

  • 肺がんは世界中で がんによる死亡の主な原因です
  • 窒素酸化物 (NO),プロスタグランジン (PG),トロンボキサン (TX),エンドセリン (ET) は生理学的プロセスに関与するシグナル分子である.
  • これらの分子は肺がん発生に重要な役割を果たし,癌細胞の増殖,アポトーシス,侵入,血管新生に影響を与えます.

研究 の 目的:

  • NO,PG,TX,ET が肺がんに与える影響について,包括的な見直しを行う.
  • NOの肺がんにおける二重の役割 (腫瘍殺菌と腫瘍発生性) を明らかにする.
  • 腫瘍抑制と促進における様々なPG (PGD2,PGE2,8-iso-PGF2α,PGI2) の特定の機能を詳細に説明する.

主な方法:

  • NO,PG,TX,ETに関する既存の研究の文献レビュー.
  • これらの薬剤が癌細胞の行動に影響を与える分子機構の分析
  • TXB2) と肺がんの進行との相関関係

主要な成果:

  • NOは肺がんにおいて腫瘍殺菌と腫瘍発生作用の両方を表している.
  • PGD2とPGI2は腫瘍抑制剤として機能し,PGE2と8-イソ-PGF2αは腫瘍の進行を促進する.
  • TXA2は増殖と血管新生を促進し,TXB2の上昇は進行段階と相関する.
  • ET-1とET-2は癌細胞の増殖と侵入を抑制し,ET-2の枯渇はアポトーシスを誘発する.
  • 結論:

    • NO,PG,TX,ETは肺がんの発症と進行の重要な媒介です.
    • 特定のプロスタグランディンは,腫瘍抑制剤または促進剤として作用し,対極的な役割を持っています.
    • エンドセリンは癌細胞の増殖と侵入を阻害し,ET-2はアポトーシスを誘発します.